# Study in Participants With Acute Migraines Headaches

> **NCT00804973** · PHASE2 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 120 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** LY2590443
- **DRUG:** Placebo injection
- **DRUG:** Sumatriptan
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT00804973
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 120 (ACTUAL)
- **Why stopped:** Due to efficacy results of interim analysis
- **Last updated:** 2020-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804973, "Study in Participants With Acute Migraines Headaches". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00804973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*